AAPG V - ASCENTAGE PHARMA GROUP INTERNATIONAL
17.7
-1.300 -7.345%
Share volume: 14,931
Last Updated: 04-10-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.01%
PREVIOUS CLOSE
CHG
CHG%
$19.00
-1.30
-0.07%
Fundamental analysis
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Performance
5 Days
-13.24%
1 Month
-6.84%
3 Months
2.61%
6 Months
2.61%
1 Year
2.61%
2 Year
2.61%
Key data
Stock price
$17.70
DAY RANGE
$17.58 - $18.50
52 WEEK RANGE
$17.00 - $24.02
52 WEEK CHANGE
$2.61
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Dajun Yang
Region: US
Website: www.ascentage.com
Employees: 600
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: www.ascentage.com
Employees: 600
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
We are a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies. Our headquarters and principal executive office is located in Suzhou, Jiangsu, China.
Recent news
